FoxO Transcription Factors: Applicability as a Novel Immune Cell Regulators and Therapeutic Targets in Oxidative Stress-Related Diseases

被引:18
|
作者
Kim, Mi Eun [1 ]
Kim, Dae Hyun [1 ]
Lee, Jun Sik [1 ,2 ]
机构
[1] Chosun Univ, Coll Nat Sci, BK21 Plus Res Team Bioact Control Technol, Dept Life Sci,Immunol Res Lab, Gwangju 61452, South Korea
[2] Chosun Univ, LKBio Inc, Business Incubator CUBI Bldg, Gwangju 61452, South Korea
基金
新加坡国家研究基金会;
关键词
FoxOs; immune cells; signaling pathway; cytokines; chemokines; HEMATOPOIETIC STEM-CELLS; NF-KAPPA-B; T-CELLS; L-SELECTIN; EXPRESSION; MEMORY; DIFFERENTIATION; ACTIVATION; HOMEOSTASIS; SURVIVAL;
D O I
10.3390/ijms231911877
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Forkhead box O transcription factors (FoxOs) play an important role in maintaining normal cell physiology by regulating survival, apoptosis, autophagy, oxidative stress, the development and maturation of T and B lymphocytes, and the secretion of inflammatory cytokines. Cell types whose functions are regulated by FoxOs include keratinocytes, mucosal dermis, neutrophils, macrophages, dendritic cells, tumor-infiltrating activated regulatory T (Tregs) cells, B cells, and natural killer (NK) cells. FoxOs plays a crucial role in physiological and pathological immune responses. FoxOs control the development and function of Foxp3+ Tregs. Treg cells and Th17 cells are subsets of CD4+ T cells, which play an essential role in immune homeostasis and infection. Dysregulation of the Th17/Treg cell balance has been implicated in the development and progression of several disorders, such as autoimmune diseases, inflammatory diseases, and cancer. In addition, FoxOs are stimulated by the mitogen-activated protein (MAP) kinase pathway and inhibited by the PI3 kinase/AKT pathway. Downstream target genes of FoxOs include pro-inflammatory signaling molecules (toll-like receptor (TLR) 2, TLR4, interleukin (IL)-1 beta, and tumor necrosis factor (TNF)-alpha), chemokine receptors (CCR7 and CXCR2), B-cell regulators (APRIL and BLYS), T-regulatory modulators (Foxp3 and CTLA-4), and DNA repair enzymes (GADD45 alpha). Here, we review the recent progress in our understanding of FoxOs as the key molecules involved in immune cell differentiation and its role in the initiation of autoimmune diseases caused by dysregulation of immune cell balance. Additionally, in various diseases, FoxOs act as a cancer repressor, and reviving the activity of FoxOs forces Tregs to egress from various tissues. However, FoxOs regulate the cytotoxicity of both CD8+ T and NK cells against tumor cells, aiding in the restoration of redox and inflammatory homeostasis, repair of the damaged tissue, and activation of immune cells. A better understanding of FoxOs regulation may help develop novel potential therapeutics for treating immune/oxidative stress-related diseases.
引用
收藏
页数:14
相关论文
共 47 条
  • [1] FOXO transcription factors as therapeutic targets in human diseases
    Orea-Soufi, Alba
    Paik, Jihye
    Braganca, Jose
    Donlon, Timothy A.
    Willcox, Bradley J.
    Link, Wolfgang
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (12) : 1070 - 1084
  • [2] The Therapeutic Potential of Supersulfides in Oxidative Stress-Related Diseases
    Pan, Yuexuan
    Matsunaga, Tetsuro
    Zhang, Tianli
    Akaike, Takaaki
    BIOMOLECULES, 2025, 15 (02)
  • [3] Oxidative Stress-Related Transcription Factors in the Regulation of Secondary Metabolism
    Hong, Sung-Yong
    Roze, Ludmila V.
    Linz, John E.
    TOXINS, 2013, 5 (04): : 683 - 702
  • [4] Apelin/APJ system: A novel therapeutic target for oxidative stress-related inflammatory diseases (Review)
    Zhou, Qun
    Cao, Jiangang
    Chen, Linxi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 37 (05) : 1159 - 1169
  • [5] Transcription factors as targets of novel therapeutic approaches of autoimmune diseases - Preface
    Neeck, G
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (23)
  • [6] Therapeutic Potential of Superoxide Dismutase Fused with Cell-Penetrating Peptides in Oxidative Stress-Related Diseases
    Wang, Xiao-Lu
    Jiang, Ren-Wang
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2022, 22 (17) : 2287 - 2298
  • [7] FOXO transcription factors in cell-cycle regulation and the response to oxidative stress
    Furukawa-Hibi, Y
    Kobayashi, Y
    Chen, C
    Motoyama, N
    ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (5-6) : 752 - 760
  • [8] Lipoprotein interactions with chromatic membranes as a novel marker for oxidative stress-related diseases
    Hanin-Avraham, Nirit
    Fuhrman, Bianca
    Mech-Dorosz, Agnieszka
    Kolusheva, Sofiya
    Porgador, Angel
    Aviram, Michael
    Jelinek, Raz
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2009, 1788 (11): : 2436 - 2443
  • [9] Therapeutic Applications of Plant-Derived Extracellular Vesicles as Antioxidants for Oxidative Stress-Related Diseases
    Kim, Manho
    Jang, Hyejun
    Kim, Wijin
    Kim, Doyeon
    Park, Ju Hyun
    ANTIOXIDANTS, 2023, 12 (06)
  • [10] MicroRNAs: Novel Regulators of Oligodendrocyte Differentiation and Potential Therapeutic Targets in Demyelination-Related Diseases
    Jia-Su Li
    Zhong-Xiang Yao
    Molecular Neurobiology, 2012, 45 : 200 - 212